ATE464378T1 - Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und - differenzierung - Google Patents

Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und - differenzierung

Info

Publication number
ATE464378T1
ATE464378T1 AT01940910T AT01940910T ATE464378T1 AT E464378 T1 ATE464378 T1 AT E464378T1 AT 01940910 T AT01940910 T AT 01940910T AT 01940910 T AT01940910 T AT 01940910T AT E464378 T1 ATE464378 T1 AT E464378T1
Authority
AT
Austria
Prior art keywords
muscle
muscle mass
acrp30
globular head
methods
Prior art date
Application number
AT01940910T
Other languages
English (en)
Inventor
Harvey Lodish
Joachim Fruebis
Tsu-Shuen Tsao
Bernard Bihain
Original Assignee
Serono Genetics Inst Sa
Whitehead Biomedical Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Genetics Inst Sa, Whitehead Biomedical Inst filed Critical Serono Genetics Inst Sa
Application granted granted Critical
Publication of ATE464378T1 publication Critical patent/ATE464378T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2264—Obesity-gene products, e.g. leptin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01940910T 2000-05-31 2001-05-22 Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und - differenzierung ATE464378T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20825100P 2000-05-31 2000-05-31
US23973500P 2000-10-11 2000-10-11
PCT/IB2001/001126 WO2001092330A2 (en) 2000-05-31 2001-05-22 Use of acrp30 globular head to promote increases in muscle mass and muscle differentiation

Publications (1)

Publication Number Publication Date
ATE464378T1 true ATE464378T1 (de) 2010-04-15

Family

ID=26903041

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01940910T ATE464378T1 (de) 2000-05-31 2001-05-22 Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und - differenzierung

Country Status (9)

Country Link
US (2) US7405193B2 (de)
EP (1) EP1294866B1 (de)
JP (1) JP2003535104A (de)
AT (1) ATE464378T1 (de)
AU (2) AU781253B2 (de)
CA (1) CA2410758A1 (de)
DE (1) DE60141827D1 (de)
IL (2) IL153200A0 (de)
WO (1) WO2001092330A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097689A1 (en) * 2002-05-17 2003-11-27 Serono Genetics Institute S.A. Obg3 fragments inhibiting the conversion of active obg3 into less active obg3 and other compositions for treatment of metabolic disorders
AU2003225410A1 (en) 2003-03-21 2004-10-11 Academisch Ziekenhuis Leiden Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
JP2008507591A (ja) * 2004-05-21 2008-03-13 ゼンコー・インコーポレイテッド 免疫原性が改変されたＣ１ｑファミリーメンバータンパク質
JP6047270B2 (ja) * 2006-08-11 2016-12-21 バイオマリン テクノロジーズ ベー．フェー． Ｄｎａリピートの不安定性に関連した遺伝的障害を治療するための方法及び手段
JP2010533170A (ja) * 2007-07-12 2010-10-21 プロセンサ テクノロジーズ ビー．ブイ． 化合物を種々の選択された臓器、組織又は腫瘍細胞に標的化するための分子
WO2009008727A2 (en) * 2007-07-12 2009-01-15 Prosensa Technologies B.V. Molecules for targeting compounds to various selected organs or tissues
USRE48468E1 (en) 2007-10-26 2021-03-16 Biomarin Technologies B.V. Means and methods for counteracting muscle disorders
NZ584793A (en) 2007-10-26 2012-05-25 Academisch Ziekenhuis Leiden Means and methods for counteracting muscle disorders
EP2088156A1 (de) 2008-02-08 2009-08-12 Institut Pasteur Verwendung von Adiponektin zur Diagnose und/oder Behandlung von Presbyakusis
EP2119783A1 (de) 2008-05-14 2009-11-18 Prosensa Technologies B.V. Verfahren für effizientes Exon (44)-Skipping bei Duchenne-Muskeldystrophie und entsprechende Mittel
CN102459595A (zh) 2009-04-24 2012-05-16 普罗森那技术公司 用于治疗dmd的包含肌苷的寡核苷酸
AU2010335039B2 (en) 2009-12-24 2015-03-26 Academisch Ziekenhuis Leiden H.O.D.N. Lumc Molecule for treating an inflammatory disorder
CA2862628C (en) 2012-01-27 2021-08-24 Prosensa Technologies B.V. Rna modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy
KR101438744B1 (ko) * 2012-08-02 2014-09-15 전남대학교산학협력단 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물
JP6539511B2 (ja) * 2015-06-17 2019-07-03 花王株式会社 運動機能の判定用マーカー
NL2015032B1 (en) 2015-06-26 2017-01-24 Vitalnext B V Compositions and methods for the treatment of malnutrition.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869330A (en) 1995-06-05 1999-02-09 Whitehead Institute For Biomedical Research DNA encoding a novel serum protein produced exclusively in adipocytes
FR2767135B1 (fr) 1997-08-06 2002-07-12 Genset Sa Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
JP3538711B2 (ja) * 1997-10-29 2004-06-14 大塚製薬株式会社 平滑筋増殖抑制組成物、動脈硬化症診断方法及びそのキット
US7338787B2 (en) 2000-01-14 2008-03-04 Serono Genetics Institute S.A. Nucleic acids encoding OBG3 globular head and uses thereof
US6989367B2 (en) 2000-01-14 2006-01-24 Genset S.A. OBG3 globular head and uses thereof
US6579852B2 (en) 2000-01-14 2003-06-17 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
US6566332B2 (en) 2000-01-14 2003-05-20 Genset S.A. OBG3 globular head and uses thereof for decreasing body mass
US20020058617A1 (en) 2000-01-14 2002-05-16 Joachim Fruebis OBG3 globular head and uses thereof for decreasing body mass
BR0107626A (pt) * 2000-01-14 2002-10-15 Genset Sa Cabeças globulares de obg3 e usos destes para diminuir a massa corporal
WO2002060466A2 (en) 2001-02-02 2002-08-08 Genset S.A. Gssp3 polynucleotides and polypeptides and uses thereof
US6867189B2 (en) 2001-07-26 2005-03-15 Genset S.A. Use of adipsin/complement factor D in the treatment of metabolic related disorders
CA2462588A1 (en) 2001-10-12 2003-04-24 Genset S.A. Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof

Also Published As

Publication number Publication date
AU2005203365B2 (en) 2008-02-14
AU2005203365A1 (en) 2005-08-25
US20060035824A1 (en) 2006-02-16
WO2001092330A2 (en) 2001-12-06
CA2410758A1 (en) 2001-12-06
IL153200A (en) 2010-05-17
IL153200A0 (en) 2003-07-06
AU781253B2 (en) 2005-05-12
US20080274971A1 (en) 2008-11-06
WO2001092330A3 (en) 2002-08-22
DE60141827D1 (de) 2010-05-27
AU7439801A (en) 2001-12-11
EP1294866A2 (de) 2003-03-26
US7405193B2 (en) 2008-07-29
JP2003535104A (ja) 2003-11-25
EP1294866B1 (de) 2010-04-14

Similar Documents

Publication Publication Date Title
DE60141827D1 (de) Verwendung des globulären kopfes von acrp30 zur verstärkung der zunahme von muskelmasse und -differenzierung
ATE305296T1 (de) Zusammensetzungen und verfahren zur behandlung von abnormaler zellvermehrung
ATE245416T1 (de) Neue fettanaloge zur behandlung von diabetes
BR0012748A (pt) Análogo super-ativo do hormÈnio de lberação do hormõnio do crescimento porcino
ATE342964T1 (de) Rekombinante alpha-l-iduronisase, deren herstellungs- und aufreinigungsverfahren, und behandlung von durch diese hervorgerufene mangelerkrankungen
ATE356113T1 (de) Probucolbernsteinsäureester zur hemmung der expression von vcam-1
CA2288445A1 (en) 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
ATE402607T1 (de) Delta-4-desaturase-gene und ihre verwendung
AP2001002217A0 (en) Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids.
PT1446162E (pt) Agrupamentos imunoestimuladores oligonucléotidos com actividade melhorada
DE69736984D1 (de) Inhibitoren des interleukin-1-beta konvertierenden enzyms
GEP20053660B (en) Novel Tyrosine Kinase Inhibitors
EA200201214A1 (ru) Замещенные тиоацетамиды
ATE459360T1 (de) Phosphoantigen enthaltene zusammensetzungen zur regulierung von immunereaktionen
NO20002702L (no) Tienopyrimidiner
AU5896098A (en) Inhibitors of interleukin-1beta converting enzyme
AU8647101A (en) Compounds having activity as inhibitors of cytochrome p450rai
DE69925581D1 (de) 1,2-diazepanderivate als inhibitoren des interleukin-1beta umwandelnden enzyms
HK1040402A1 (zh) 使用乳粘素(lactadherin)或其變體的的方法及其組合物
ATE284217T1 (de) Verwendung von sulphoquinovosyldiacylglycerols zur behandlung von entzündlichen hauterkrankungen
ATE317381T1 (de) Sulfonamid-substituierte asparaginsäuren als inhibitoren von interleukin-1beta-konvertierenden enzymen
BE1002375A3 (fr) Matieres biologiques, procede pour la production de matieres biologiques et pour l'utilisation de telles matieres en therapie.
DE60027127D1 (de) Verwendung von Polyaminosäurederivaten zur Behandlung von Seborrhoe und verwandten Hautstörungen
DE69932922D1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
ATE218334T1 (de) Verwendung von gabapentin in der behandlung vonangst - und panikstörungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties